Quantcast
Last updated on April 17, 2014 at 11:16 EDT

Latest Aortic valve stenosis Stories

2009-07-22 13:27:04

 Over the last four years, heart specialists at NewYork-Presbyterian Hospital/Columbia University Medical Center have implanted an innovative aortic heart valve replacement using a catheter-based approach that does not require open-heart surgery in a total of 100 patients -- the most of any U.S. medical center to date.Open-heart surgery can require a two- to three-month recovery period, compared to only a few days for the transcatheter approach.The procedures were conducted as part of...

2009-06-10 10:07:15

Bicuspid Aortic Valve (BAV), a condition in which patients' aortic valves have just two leaflets instead of the normal three, is the most common cardiac anomaly, affecting up to two percent of the general population. The defect can result in calcification deposits on the heart valve, leakage of the valve and may results in a feeling of tightness in the chest as well as shortness of breath. The condition is easily diagnosed; often physicians can hear a "click" or a murmur when they listen to a...

2009-02-11 09:10:01

When 91-year-old Irvin Lafferty was diagnosed with severe blockage of his heart valve"”hardening that is formally known as aortic valve stenosis"”open-heart surgery was out of the question.  He'd already survived quadruple bypass while in his 50s, and having lived almost a century, Lafferty wasn't a good candidate for heart surgery for many reasons.  His local cardiologist referred him to surgical and interventional specialists at Chicago's Bluhm Cardiovascular Institute...

2009-01-21 13:42:00

DALLAS, Jan. 21 /PRNewswire-USNewswire/ -- Clinical studies that may influence medical care and research that demonstrates how science can be effectively applied in the real world top the list of cardiovascular disease and stroke advances from 2008, said Timothy Gardner, M.D., president of the American Heart Association. The American Heart Association has been compiling an annual list of the top 10 major advances in heart disease and stroke research since 1996. "It's always difficult to...

2008-10-21 09:00:54

FOR U.S. AUDIENCES ONLY The Medicines Company (NASDAQ: MDCO) today announced that poor blood pressure control during cardiac surgery is associated with a higher risk of 30-day death, stroke, myocardial infarction and renal dysfunction, compared to patients with tight blood pressure control, according to a post-hoc analysis of the ECLIPSE trial. The data were presented at the American Society of Anesthesiologists (ASA) 2008 Annual Meeting. "In this analysis, what we found was clear: the...

2008-10-13 15:00:31

CoreValve (www.corevalve.com) announced today that the expanded clinical evaluation of its ReValving(R) System for percutaneous aortic valve replacement (PAVR) in high-risk patients with aortic stenosis continues to enroll patients at an accelerating pace. More than 1,800 patients have now been treated worldwide at nearly 100 centers in 20 countries. During the Monday Transcatheter Aortic Valve Replacement sessions at TCT 2008 meeting in Washington, D.C., CoreValve investigators and...

2008-09-05 15:00:31

DEAR DR. DONOHUE: I am a 15-year-old girl with less-than-perfect skin. My back, chest and face break out constantly. My mom suggested taking birth control pills, but I am hesitant. Fifteen seems too early. My mom was recently hospitalized for a blood clot, and the doctors said it could have been caused by the birth control pill. I currently am taking minocycline, but it doesn't always work. What should I do? - H.F. ANSWER: Fighting acne involves conducting warfare on many fronts. One front...

2008-08-26 09:01:20

The Medicines Company (NASDAQ: MDCO) today announced that the results of VELOCITY, a pivotal Phase 3 safety and efficacy trial of its new intravenous (IV) therapy Cleviprex(TM) (clevidipine butyrate) injectable emulsion, were published in the August issue of the Annals of Emergency Medicine. The clinical trial demonstrated that Cleviprex is safe and effective for the treatment of acute, severe hypertension. Cleviprex was approved this month by the U.S. Food and Drug Administration (FDA) for...

2008-08-23 00:00:09

The U.S. Food and Drug Administration said it is investigating a report of a possible increased cancer risk for patients who take the drug Vytorin. Vytorin is a combination of simvastatin, marketed as Zocor, and ezetimibe, marketed as Zetia. It was approved as a combination drug in 2004 to reduce LDL-choloesterol levels. Preliminary results of a clinical trial to see if lowering LDL-cholesterol with Vytorin would reduce the risk of major cardiovascular events in patients with aortic...

2008-07-23 15:00:14

By LINDA A. JOHNSON, THE ASSOCIATED PRESS TRENTON In the latest disappointment for cholesterol pill Vytorin, a major European study of patients with heart valve disease found the drug didn't prevent worsening of the disease or lower the need for valve surgery. The news sent its makers' stock plunging. Results of a preliminary analysis of the study showed Vytorin, marketed jointly by Merck & Co. and Schering-Plough Corp., was no better than placebo at lowering the risk of major...